scholarly journals T lymphocytes of the normal human cornea.

1987 ◽  
Vol 71 (5) ◽  
pp. 384-386 ◽  
Author(s):  
O F Scheiffarth ◽  
F H Stefani ◽  
N Gabriel ◽  
O E Lund
1988 ◽  
Vol 28 (4) ◽  
pp. 340
Author(s):  
Scheiffarth OF ◽  
Stefani F ◽  
Gabriel N ◽  
Lund O

1994 ◽  
Vol 313 (2-3) ◽  
pp. 227-247 ◽  
Author(s):  
Derek R. Robinson ◽  
Kevin Goodall ◽  
Richard J. Albertini ◽  
J.Patrick O'Neill ◽  
Barry Finette ◽  
...  

2008 ◽  
Vol 80 (1) ◽  
pp. 114-121 ◽  
Author(s):  
E. F. SROUR ◽  
T. LEEMHUIS ◽  
L. JENSKI ◽  
R. REDMOND ◽  
D. FILLAK ◽  
...  

Blood ◽  
1996 ◽  
Vol 88 (5) ◽  
pp. 1747-1754 ◽  
Author(s):  
J Drach ◽  
A Gsur ◽  
G Hamilton ◽  
S Zhao ◽  
J Angerler ◽  
...  

Abstract The physiological role of the multidrug resistance P-glycoprotein (P- gp), which is expressed by normal human T lymphocytes, is still largely unknown. To investigate whether or not P-gp is involved in the transport of cytokines, peripheral blood lymphocytes were stimulated with phytohemagglutinin (PHA) in the absence or presence of P-gp inhibitors, and concentrations of cytokines (interleukin-2 [IL-2], IL- 4, IL-6, interferon-gamma [IFN-gamma]) in the supernatants of these cultures were quantitated by enzyme-linked immunosorbent assay. P-gp inhibitors included verapamil (Ver), tamoxifen (Tmx), and the P-gp specific monoclonal antibody UIC2. Release of IL-2 was significantly suppressed by these inhibitors at concentrations that were also effective in blocking efflux of Rhodamine-123 from normal T lymphocytes. IL-2 mRNA expression in lymphocytes was not different between PHA control and the cultures with P-gp inhibitors. Ver and Tmx did not interfere with T-cell activation as determined by CD25 and CD69 expression. In a nonhematological model, the P-gp expressing HCT-8 adenocarcinoma cell line, exogenously added IL-2 was shown to exert an inhibitory effect on P-gp mediated Rhodamine-123 efflux. In addition, transepithelial transport of IL-2 by electrophysiologically tight and polarized HCT-8 monolayers was examined. A time-dependent flux of IL-2 across dense monolayers, which was partially inhibited by Ver, was observed. We also investigated whether or not P-gp inhibitors suppressed release of other cytokines produced by activated T cells (IL- 4, IL-6, IFN-gamma). Release of IL-4 and IFN-gamma was significantly inhibited by Ver, Tmx, and UIC2; however, release of IL-6 remained unaffected. These data show P-gp mediated transmembrane flux of IL-2 in T lymphocytes and HCT-8 cells. We conclude that P-gp participates in the transport of cytokines (IL-2, IL-4, and IFN-gamma) in normal peripheral T lymphocytes.


Blood ◽  
1994 ◽  
Vol 84 (10) ◽  
pp. 3413-3421 ◽  
Author(s):  
A Szepesi ◽  
EW Gelfand ◽  
JJ Lucas

Abstract The proliferating cell nuclear antigen (PCNA) is an auxiliary protein of DNA polymerase delta and appears to be needed for both DNA synthesis and DNA repair. It is present in low amount in resting normal human T lymphocytes and, upon mitogenic stimulation with phorbol dibutyrate and ionomycin, begins to increase in mid-G1 phase, approximately 12 to 15 hours before entry into S phase. PCNA continues to increase in amount throughout the cell cycle and remains high in proliferating cultures. PCNA was extracted from activated normal T cells and from the transformed T-lymphoblastoid cell line Jurkat by a method that recovered approximately 98% of total cellular PCNA but yet retained its associations with other proteins. PCNA immunoprecipitates possessed H1 histone kinase activity, which increased in parallel with increasing cellular content of PCNA. Both the cdc2 and cdk2 kinases were found associated with PCNA in normal T cells, in amounts consistent with detected kinase activity. The results indicate that PCNA is not an inhibitory molecule of cdk/cyclin activity. Both normal and transformed T cells contained PCNA in association with cdk2, cdk4, cdk5, and cdk6, with the amount of PCNA associated with these molecules increasing in the order listed. Relatively high amounts of PCNA were also found associated with cyclins D2 and D3, the major cyclin partners of cdk6 in T cells. Though detected in normal cells, PCNA/cdc2 complexes were present in exceedingly low amount, if at all, in Jurkat cells. This cell line appeared to contain more of nearly all of the cdk and cyclin molecules analyzed, but there seemed to be little difference in the patterns of association of these molecules with PCNA in the cell line as compared with normal human T cells.


Biochimie ◽  
2020 ◽  
Vol 174 ◽  
pp. 34-43
Author(s):  
Dmitry D. Zhdanov ◽  
Anna A. Plyasova ◽  
Vadim S. Pokrovsky ◽  
Marina V. Pokrovskaya ◽  
Svetlana S. Alexandrova ◽  
...  

1993 ◽  
Vol 204 (2) ◽  
pp. 260-267 ◽  
Author(s):  
Naohiro Terada ◽  
Reuven Or ◽  
Agota Szepesi ◽  
Joseph J. Lucas ◽  
Erwin W. Gelfand

2009 ◽  
Vol 46 (3) ◽  
pp. 345-354 ◽  
Author(s):  
Kassiani Liopeta ◽  
Stavroula Boubali ◽  
Laura Virgilio ◽  
George Thyphronitis ◽  
George Mavrothalassitis ◽  
...  

1985 ◽  
Vol 93 (6) ◽  
pp. 513-521 ◽  
Author(s):  
JESPER REIBEL ◽  
ERIK DABELSTEEN ◽  
BIRGIT KENRAD ◽  
KARSTEN BUSCHARD

Sign in / Sign up

Export Citation Format

Share Document